Arcadia Biosciences Inc [NASDAQ: RKDA] gained 31.36% on the last trading session, reaching $4.44 price per share at the time.
Arcadia Biosciences Inc represents 1.37 million in outstanding shares, while the company has a total market value of $6.07 million with the latest information. RKDA stock price has been found in the range of $3.43 to $6.71.
If compared to the average trading volume of 8.01K shares, RKDA reached a trading volume of 6170791 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Arcadia Biosciences Inc [RKDA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RKDA shares is $12.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RKDA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Arcadia Biosciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 17, 2020. The new note on the price target was released on May 12, 2017, representing the official price target for Arcadia Biosciences Inc stock. Previously, the target price had yet another raise to $10, while Piper Jaffray analysts kept a Overweight rating on RKDA stock.
The Price to Book ratio for the last quarter was 1.34, with the Price to Cash per share for the same quarter was set at 3.25.
Trading performance analysis for RKDA stock
Arcadia Biosciences Inc [RKDA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 27.95. With this latest performance, RKDA shares gained by 39.42% in over the last four-week period, additionally plugging by 62.46% over the last 6 months – not to mention a drop of -25.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RKDA stock in for the last two-week period is set at 70.78, with the RSI for the last a single of trading hit 0.54, and the three-weeks RSI is set at 0.36 for Arcadia Biosciences Inc [RKDA]. The present Moving Average for the last 50 days of trading for this stock 3.85, while it was recorded at 3.65 for the last single week of trading, and 4.18 for the last 200 days.
Arcadia Biosciences Inc [RKDA]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Arcadia Biosciences Inc [RKDA] shares currently have an operating margin of -171.02% and a Gross Margin at 37.78%. Arcadia Biosciences Inc’s Net Margin is presently recorded at -139.33%.
Arcadia Biosciences Inc (RKDA) Capital Structure & Debt Analysis
According to recent financial data for Arcadia Biosciences Inc. ( RKDA), the Return on Equity (ROE) stands at -87.18%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -56.27%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Arcadia Biosciences Inc’s Return on Invested Capital (ROIC) is -166.23%, showcasing its effectiveness in deploying capital for earnings.
Arcadia Biosciences Inc (RKDA) Efficiency & Liquidity Metrics
Based on Arcadia Biosciences Inc’s (RKDA) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Arcadia Biosciences Inc (RKDA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Arcadia Biosciences Inc. (RKDA) effectively leverages its workforce, generating an average of -$837777.78 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.12% and a Quick Ratio of 3.31%, indicating strong ability to cover short-term liabilities.
Arcadia Biosciences Inc [RKDA]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Arcadia Biosciences Inc posted -0.87/share EPS, while the average EPS was predicted by analysts to be reported at -0.77/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.1. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RKDA.
An analysis of Institutional ownership at Arcadia Biosciences Inc [RKDA]
There are presently around $4.33%, or 4.37%% of RKDA stock, in the hands of institutional investors. The top three institutional holders of RKDA stocks are: VANGUARD GROUP INC with ownership of 14038.0 shares, which is approximately 1.0301%. STATE STREET CORP, holding 12146.0 shares of the stock with an approximate value of $$38260.0 in RKDA stocks shares; and STATE STREET CORP, currently with $$5616.0 in RKDA stock with ownership which is approximately 0.1308%.
